Venture Capital Investors

Longitude Capital Management

VC investing group Longitude Capital Management provides capital to innovative tech companies.

Venture Investor Overview

Venture Investor
Longitude Capital Management
Status
Active
Investor Type
Venture Capital
Activity Level
102 transactions
Funds Raised
At least $1.2 billion
Industry Focus
Biopharmaceutical
Healthcare IT
Healthcare Services
Medical Devices & Instruments

Contact Information

Contact
Juliet Bakker
Title
Managing Director
Mailing Address
2740 Sand Hill Rd. 2nd Floor
Menlo Park, CA 94025
USA
Phone
(650) 854-5700
Website
www.longitudecapital.com
Email Address
Not Recorded

Background Information

Overview
Longitude Capital is a life sciences venture capital firm specializing in investments in medical devices, biotechnology and pharmaceutical development. We consider companies across all therapeutic indications and stages of development.
Profile
Longitude Capital Management LinkedIn Company Profile
Social Media
Longitude Capital Management Company Twitter Account
Company News
Longitude Capital Management News
Facebook
Longitude Capital Management on Facebook
YouTube
Longitude Capital Management on YouTube
Last Transaction
2/13/2024

Transaction History

Our records indicate that Longitude Capital Management invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
BioAge Labs
2/13/2024
$170,000,000
Cohere Health
2/2/2024
$50,000,000
Nalu Medical
1/4/2024
$65,000,000
Lassen Therapeutics
12/20/2023
$85,000,000
OrsoBio
11/7/2023
$60,000,000
CG Oncology
8/3/2023
$105,000,000
Quanta Therapeutics
5/22/2023
$50,700,000
Cortica
4/18/2023
$75,000,000
nOCD
1/31/2023
$34,000,000
Alpha-9 Theranostics
12/14/2022
$75,000,000
Opna Bio
11/22/2022
$38,000,000
CG Oncology
11/15/2022
$120,000,000
Zenas BioPharma
11/8/2022
$118,000,000
Rivus Pharmaceuticals
9/22/2022
$132,000,000
IntelyCare
4/6/2022
$115,000,000
Somatus
3/19/2022
$325,000,000
Avenge Bio
1/11/2022
$45,000,000
LEXEO Therapeutics
9/10/2021
$100,000,000
Sydnexis
8/11/2021
$45,000,000
Rivus Pharmaceuticals
7/22/2021
$35,000,000
Cortica
6/30/2021
$60,000,000
Ceribell
5/3/2021
$53,000,000
Cohere Health
4/14/2021
$36,000,000
Theseus Pharmaceuticals
4/14/2021
$100,000,000
Amunix Pharmaceuticals
3/5/2021
$117,000,000
Vera Therapeutics
1/22/2021
$80,000,000
LEXEO Therapeutics
1/11/2021
$85,000,000
Endeavor BioMedicines
1/8/2021
$62,000,000
Talaris Therapeutics
10/7/2020
$115,000,000
Eargo
7/30/2020
$71,000,000
Somatus
6/24/2020
$64,000,000
Checkmate Pharmaceuticals
6/11/2020
$85,000,000
Rapid Micro Biosystems
5/21/2020
$120,000,000
Dascena
5/1/2020
$50,000,000
SutroVax
3/27/2020
$110,000,000
Amunix Pharmaceuticals
3/5/2020
$73,000,000
Epirium
12/19/2019
$85,000,000
Poseida Therapeutics
4/23/2019
$142,000,000
Talaris Therapeutics
4/19/2019
$100,000,000
Inozyme Pharma
4/11/2019
$67,000,000
Tiburio Therapeutics
1/4/2019
$31,000,000
89Bio
10/26/2018
$60,000,000
CuraSen Therapeutics
10/18/2018
$54,500,000
Velicept Therapeutics
10/17/2018
$15,000,000
WelbeHealth
6/30/2018
$15,000,000
SutroVax
6/8/2018
$85,000,000
Sublimity Therapeutics
5/23/2018
$64,000,000
Murj
5/10/2018
$8,500,000
Neurana Pharmaceuticals
5/8/2018
$60,000,000
Rapid Micro Biosystems
5/3/2018
$60,000,000
Axonics Modulation Technologies
4/4/2018
$40,100,000
Poseida Therapeutics
4/4/2018
$30,500,000
Aptinyx
12/19/2017
$70,000,000
Inozyme Pharma
11/16/2017
$49,000,000
Tricida
11/9/2017
$57,500,000
Cydan
10/18/2017
$34,000,000
Amphora Medical
7/21/2017
$35,500,000
SutroVax
3/22/2017
$64,000,000
Tricida
7/26/2016
$55,000,000
Aptinyx
5/11/2016
$65,000,000
Kala Pharmaceuticals
4/14/2016
$68,000,000
Zavante Therapeutics
3/30/2016
$45,000,000
Velicept Therapeutics
12/3/2015
$21,000,000
BAROnova
11/24/2015
$36,500,000
Alphaeon
11/13/2015
$70,000,000
Orbus Therapeutics
8/21/2015
$32,500,000
SutroVax
7/24/2015
$22,000,000
CardioDx
6/30/2015
$5,000,000
Calhoun Vision
6/30/2015
$68,999,900
Rapid Micro Biosystems
6/30/2015
$18,680,100
InfaCare Pharmaceutical
6/30/2015
$20,000,000
Allergen Research
3/12/2015
$80,000,000
Collegium Pharmaceutical
3/11/2015
$50,000,000
Civitas Therapeutics
8/25/2014
$55,000,000
Rapid Micro Biosystems
4/16/2014
$6,001,413
AqueSys
1/16/2014
$43,600,000
Ajax Vascular
12/31/2013
$500,000
Practice Fusion
12/9/2013
$15,000,000
Civitas Therapeutics
9/11/2013
$38,000,000
Allergen Research
6/30/2013
$5,000,000
Rapid Micro Biosystems
6/26/2013
$32,600,000
Esperion Therapeutics
4/25/2013
$33,000,000
InfaCare Pharmaceutical
3/31/2013
$3,312,000
Sympara Medical
3/31/2013
$4,300,000
Precision Dermatology
12/31/2012
$25,599,900
CardioDx
12/31/2012
$5,998,000
CardioDx
8/27/2012
$58,000,000
Aptus Endosystems
6/28/2012
$25,000,000
Collegium Pharmaceutical
2/22/2012
$22,500,000
PixelOptics
4/7/2011
$45,000,000
CardioDx
3/31/2011
$60,000,000
Civitas Therapeutics
1/10/2011
$20,000,000
Aptus Endosystems
8/30/2010
$15,000,000
AqueSys
6/29/2010
$35,000,000
Precision Therapeutics
6/11/2010
$35,000,000
Facet Solutions
4/23/2010
$2,100,000
Solta Medical
1/11/2010
$17,200,000
Aptus Endosystems
12/31/2008
$20,299,700
Precision Therapeutics
11/10/2008
$43,000,000
InfaCare Pharmaceutical
10/27/2008
$28,000,000
PixelOptics
10/23/2008
$30,000,000
VeloMedix
9/30/2008
$4,653,200

 

Investor Contacts

Title
Name
Email & Social
Managing Director
Sandip Agarwala
  Sandip Agarwala LinkedIn Profile  Sandip Agarwala Twitter Account  Sandip Agarwala News  Sandip Agarwala on Facebook
Managing Director
Juliet Bakker
  Juliet Bakker LinkedIn Profile  Juliet Bakker Twitter Account  Juliet Bakker News  Juliet Bakker on Facebook
Managing Director
Patrick Enright
  Patrick Enright LinkedIn Profile  Patrick Enright Twitter Account  Patrick Enright News  Patrick Enright on Facebook
Managing Director
Marc Galletti
  Marc Galletti LinkedIn Profile  Marc Galletti Twitter Account  Marc Galletti News  Marc Galletti on Facebook
Managing Director
Gregory Grunberg
  Gregory Grunberg LinkedIn Profile  Gregory Grunberg Twitter Account  Gregory Grunberg News  Gregory Grunberg on Facebook
Managing Director
David Hirsch
  David Hirsch LinkedIn Profile  David Hirsch Twitter Account  David Hirsch News  David Hirsch on Facebook
Managing Director
Josh Richardson
  Josh Richardson LinkedIn Profile  Josh Richardson Twitter Account  Josh Richardson News  Josh Richardson on Facebook

 

Funds

Our database includes the following fund closing(s) for Longitude Capital Management. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Longitude Venture Partners III
6/8/2016
$525,000,000
Longitude Venture Partners II
9/5/2012
$385,000,000
Longitude Venture Partners
7/8/2008
$325,000,000

 

Portfolio Companies

Longitude Capital Management has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
89Bio
Ajax Vascular
Allergen Research
Alpha-9 Theranostics
Alphaeon
Amphora Medical
Amunix Pharmaceuticals
Aptinyx
Aptus Endosystems
AqueSys
Avenge Bio
Axonics Modulation Technologies
BAROnova
BioAge Labs
Calhoun Vision
CardioDx
Ceribell
CG Oncology
Checkmate Pharmaceuticals
Civitas Therapeutics
Cohere Health
Collegium Pharmaceutical
Cortica
CuraSen Therapeutics
Cydan
Dascena
Eargo
Endeavor BioMedicines
Epirium
Esperion Therapeutics
Facet Solutions
InfaCare Pharmaceutical
Inozyme Pharma
IntelyCare
Kala Pharmaceuticals
Lassen Therapeutics
LEXEO Therapeutics
Murj
Nalu Medical
Neurana Pharmaceuticals
nOCD
Opna Bio
Orbus Therapeutics
OrsoBio
PixelOptics
Poseida Therapeutics
Practice Fusion
Precision Dermatology
Precision Therapeutics
Quanta Therapeutics
Rapid Micro Biosystems
Rivus Pharmaceuticals
Solta Medical
Somatus
Sublimity Therapeutics
SutroVax
Sydnexis
Sympara Medical
Talaris Therapeutics
Theseus Pharmaceuticals
Tiburio Therapeutics
Tricida
Velicept Therapeutics
VeloMedix
Vera Therapeutics
WelbeHealth
Zavante Therapeutics
Zenas BioPharma

 

 

 

 

Browse more venture capital investors:

Longfellow Ventures | Longley Capital

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.